drugset
drugset / Trial / NCT03933488

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants

NCT03933488 ↗

Phase 1 Completed 121 enrolled Takeda
RandomizedSequentialDouble-blindOther

Summary

The purpose of this study is to assess the safety and tolerability of TAK-994 following single and multiple oral doses in healthy non-Japanese and Japanese adult participants and healthy elderly participants.

Timeline

Start
2019-05-01
Primary completion
2020-03-29
Completion
2020-03-29

Drugs

EvaluationDrugModalityDoseRoute
Subject TAK-994 Unknown — Oral

Indications

No indication recorded.